Article
Pancreatic MRI Findings in High-Risk Individuals Compared With Matched Average-Risk Individuals.
Pancreas - 1 Aug 2026
Sanoba Shenin A, Shen Yiqiu, Rasromani Ebrahim, Chui Wan F, Lee Michelle, Stock Miriam R, Chen Grace, Laboy Morales Diego A, Hughes Veronika, Faiz Jennifer, Stender Cody A, Jin Xiaohong, Everett Jessica N, Simeone Diane M, Gonda Tamas, Huang Chenchan
Abstract excerpt
OBJECTIVES: Pancreatic ductal adenocarcinoma (PDAC) screening is recommended for high-risk individuals (HRI) with familial pancreatic cancer (FPC) or certain pathogenic germline variants (PGVs). Screening MRI commonly identifies pancreatic cystic lesions (PCLs), but comparative data between HRI and average-risk individuals (ARI) are limited. We aimed to quantify and characterize PCL differences between these...
Topics
Join the communities discussing this publication.
